Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Alex Watt

Sanofi offers refunds for Cablivi in novel model for rebates

Pharmaceutical Technology

JANUARY 27, 2023

Designing risk sharing agreements Overall however, this warranty program is similar to previous performance-based risk sharing agreements, says Alex Watt, principal research analyst on GlobalData’s Price Intelligence team. GlobalData is the parent company of Pharmaceutical Technology.

Patients

Patients Pharmaceutical Manufacturing Healthcare Provider

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

MARCH 17, 2023

Over the last twenty years, there has been a major rise in risk sharing agreements in the pharmaceutical space, said Alex Watt, GlobalData’s principal research analyst, at a recent webinar on the same topic. She further pointed out that 73% of risk sharing agreements have been associated with a positive reimbursement decision.

Marketing

Marketing Pharma Pharmaceutical Healthcare

Sanofi offers refunds for Cablivi in novel model for rebates

Risk sharing agreements soar as market access risk increases

Stay Connected